-
Mashup Score: 1Over a decade of abiraterone: the drug that revolutionised advanced prostate cancer care - 1 year(s) ago
This Prostate Cancer Awareness Month, we’re celebrating over 10 years since abiraterone was first recommended by NICE in England as a treatment for advanced prostate cancer. We share the story of the drug’s discovery, how a landmark trial changed the way advanced prostate cancer is treated today, and what the drug has meant for patients who are currently treated with it.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Over a decade of abiraterone: the drug that revolutionised advanced prostate cancer care - 1 year(s) ago
This Prostate Cancer Awareness Month, we’re celebrating over 10 years since abiraterone was first recommended by NICE in England as a treatment for advanced prostate cancer. We share the story of the drug’s discovery, how a landmark trial changed the way advanced prostate cancer is treated today, and what the drug has meant for patients who are currently treated with it.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Being aware of a strong family history of prostate cancer is linked to an increased chance of surviving the disease, new research suggests.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4
The last decade has brought major advances in the way we diagnose and treat prostate cancer and men with advanced disease are living longer than ever. Diana Cano spoke to our scientists about the most exciting research areas that have the potential to revolutionise prostate cancer treatment in years to come.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Advanced radiotherapy safely treats prostate cancer patients in a quarter of the time of current standard - 1 year(s) ago
An advanced radiotherapy technique can be used to safely treat prostate cancer patients in as little as one to two weeks, compared with the current standard, which takes one to two months.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Prostate cancer - The Institute of Cancer Research, London - 1 year(s) ago
Our researchers are renowned for their success in improving treatments for men with prostate cancer.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0African American Prostate Cancer Patients Twice as Likely to Have More Aggressive Disease - 2 year(s) ago
New Moffitt study confirms genomic testing can help identify those with high-risk disease
Source: Moffitt Cancer CenterCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Facebook - 2 year(s) ago
Sidney Kimmel Cancer Center – Jefferson Health 2h Shared with PublicMihir Shah, MD, Clinical Assistant Professor, Department of Urology, answers some common questions about prostate cancer for #ProstateCancerAwarenessMonth.* What causes prostate cancer? What are the risk factors?There are a few risk factors that can place a man at risk for prostate cancer. These include age, ethnicity, and family…
Source: www.facebook.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Jim Senary: Prostate Cancer Patient Story | Cleveland Clinic - 2 year(s) ago
When the Urology team at Cleveland Clinic asked Jim Senary to be the first patient to trial a new surgical procedure to remove his prostate cancer, he said “yes” without thinking twice.
Source: Cleveland ClinicCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 2Prostate Cancer Causes, Risk Factors, and Prevention - 2 year(s) ago
Get information about the risks and benefits of early detection tests for prostate cancer screening
Source: www.cancer.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Abiraterone has helped to extend the lives of thousands of men like Alfred, Rob and Tony around the world. Read more about the discovery and development of abiraterone below (5/5). #ProstateCancerAwarenessMonth https://t.co/gkQTZ2MCa4